William H. Carson, M.D. is President and Chief Executive Officer of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), a company of the Tokyo-based Otsuka Pharmaceutical Company, which reports to Otsuka Holdings.
Dr. Carson has a proven track record of successful clinical development of pharmaceutical compounds leading to worldwide regulatory authority approvals and oversees the development of Otsuka’s global compounds. He led the enterprise-wide reorganization of Pharmacovigilance and Safety for Otsuka. He also represented Otsuka on the Board of Directors of PhRMA.
Dr. Carson is on the Board of Directors of OPDC, Avanir, and he is the Board Chair of Otsuka Digital Health. He is currently the Chair of the Board of the Sphinx Organization, which promotes diversity in the arts.
Dr. Carson is a member of the American Psychiatric Association, the National Medical Association. He is a board-certified psychiatrist and holds a Bachelor of Arts degree from Harvard College and a Doctor of Medicine from Case Western Reserve University.
